Context Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Context Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Context Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Context Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $129 | 114 | 1.13 |
| 2023-09-30 | $163 | 108 | 1.51 |
| 2023-06-30 | $170 | 107 | 1.60 |
| 2022-12-31 | $66 | 101 | 0.65 |
| 2022-09-30 | $0 | 99 | 0.00 |
| 2022-06-30 | $0 | 69 | 0.00 |
| 2022-03-31 | $0 | 64 | 0.00 |
| 2021-12-31 | $0 | 33 | 0.00 |